These data also suggest care should be taken when exploring TGF-β inhibitors, as immune checkpoint inhibitor expression may remain unaffected while CD103 expression is attenuated, preventing T cell retention and cytolytic activity in the tumor micro-environment. This evidence concerns the gene ITGAE and neoplasm.